$SSRM Cashflow Statement | Understand Stock

$SSRM

$29.11 -$0.15 (0.51%) Pre-market

$SSRM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net income (loss)
Adjustments for:
Depreciation, depletion, and amortization
Amortization of debt discount
Reclamation accretion expense
Reclamation and remediation costs
Payments for reclamation and remediation costs
Deferred income taxes
Loss on redemption of convertible debt
Stock-based compensation
Equity (income) loss of affiliates
Unrealized loss (gain) on derivative instruments
Change in fair value of marketable securities
Non-cash fair value adjustment on acquired inventories
Write-down of inventory
Loss (gain) on sale and disposal of assets, net
Gain on acquisition of Kartaltepe
Impairment charges
Impairment charges of long-lived and other assets
Impairment charges of goodwill
Total impairment charges
Change in fair value of deferred and contingent consideration
Other taxes
Loss (gain) on foreign exchange
Non-cash care and maintenance
Other operating activities
Net change in operating assets and liabilities

Net cash provided by operating activities
Investing activities
Additions to mineral properties, plant and equipment
Acquisitions, net
Purchases of marketable securities
Proceeds on Royalty Portfolio sale
Proceeds from sales of marketable securities
Proceeds from repayment of note receivable
Proceeds from sale of mineral properties, plant and equipment
Acquisition of non-controlling interest
Acquisition of Alacer, cash, cash equivalents and restricted cash
Other investing activities
Net cash provided by (used in) investing activities

Financing activities
Repayment of debt, principal
Redemption of convertible notes
Proceeds from issuance of convertible notes, net of transaction costs
Proceeds from issuance of debt
Proceeds from the issuance of debt, related party
Repurchase of common shares
Proceeds from exercise of stock options
Principal payments on finance leases
Non-controlling interest dividend
Dividends paid
Settlement of restricted and performance share units
Other financing activities
Net cash provided by (used in) financing activities

Effect of foreign exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash, beginning of year
Cash, cash equivalents, and restricted cash, end of year
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents
Restricted cash

Comments